Last updated: October 19, 2023
Sponsor: MRC/UVRI and LSHTM Uganda Research Unit
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Ebola+D intervention
Clinical Study ID
NCT06093646
RGEK230305
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Community member of Mubende district staying within the catchment area of the primaryhealth care facility (PHCF);
- 18years and above,
- Able to communicate in either English or Luganda (local language spoken in the studyregion and the language into which the questionnaires will be translated),
- Has a WHO SRQ-20 score of 6 and above (except for Ebola survivors who are eligibleeven when their SRQ-20 score is either below or above 6). -
Exclusion
Exclusion Criteria:
- Unable to engage with the research process for any reason that may include sensoryimpairment or cognitive impairment
Study Design
Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Ebola+D intervention
Phase:
Study Start date:
September 22, 2023
Estimated Completion Date:
August 15, 2024
Study Description
Connect with a study center
Mubende Regional Referal Hospital
Kampala,
UgandaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.